DarioHealth Corp. (DRIO) stock
DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.15−0.11 (-8.73%)
Close on Nov 16, 2026Market cap $11.27MP/E 0.3Yield –
DarioHealth gross margin
Gross margin is gross profit as a percentage of revenue.
DarioHealth's gross margin for the twelve months ending Jun 30, 2026 was 58.2%. For fiscal 2025 it was 56.6%, against 49.1% the year before. The highest annual figure on record is 56.6% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 56.6% | +7.6 |
| FY2024 | Dec 31, 2024 | 49.1% | +19.7 |
| FY2023 | Dec 31, 2023 | 29.4% | −5.5 |
| FY2022 | Dec 31, 2022 | 34.9% | +15.6 |
| FY2021 | Dec 31, 2021 | 19.3% | −13.9 |
| FY2020 | Dec 31, 2020 | 33.2% | −1.2 |
| FY2019 | Dec 31, 2019 | 34.4% | +10.5 |
| FY2018 | Dec 31, 2018 | 23.9% | −1.5 |
| FY2017 | Dec 31, 2017 | 25.4% | +55.0 |
| FY2016 | Dec 31, 2016 | -29.6% | +74.3 |
| FY2015 | Dec 31, 2015 | -103.9% | +5213.8 |
| FY2014 | Dec 31, 2014 | -5317.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 61.7% | +6.5 |
| Q1 FY2026 | Mar 31, 2026 | 57.3% | −0.2 |
| Q4 FY2025 | Dec 31, 2025 | 53.6% | −1.7 |
| Q3 FY2025 | Sep 30, 2025 | 60.2% | +8.0 |
| Q2 FY2025 | Jun 30, 2025 | 55.2% | +11.1 |
| Q1 FY2025 | Mar 31, 2025 | 57.5% | +15.3 |
| Q4 FY2024 | Dec 31, 2024 | 55.3% | +51.6 |
| Q3 FY2024 | Sep 30, 2024 | 52.2% | +34.9 |
| Q2 FY2024 | Jun 30, 2024 | 44.1% | +10.3 |
| Q1 FY2024 | Mar 31, 2024 | 42.2% | −2.6 |
| Q4 FY2023 | Dec 31, 2023 | 3.7% | −36.5 |
| Q3 FY2023 | Sep 30, 2023 | 17.3% | −9.9 |
| Q2 FY2023 | Jun 30, 2023 | 33.7% | +15.3 |
| Q1 FY2023 | Mar 31, 2023 | 44.8% | −4.6 |
| Q4 FY2022 | Dec 31, 2022 | 40.1% | +31.0 |
| Q3 FY2022 | Sep 30, 2022 | 27.3% | +12.6 |
| Q2 FY2022 | Jun 30, 2022 | 18.4% | −10.3 |
| Q1 FY2022 | Mar 31, 2022 | 49.4% | +19.4 |
| Q4 FY2021 | Dec 31, 2021 | 9.1% | −17.3 |
| Q3 FY2021 | Sep 30, 2021 | 14.7% | −12.2 |
| Q2 FY2021 | Jun 30, 2021 | 28.7% | −6.9 |
| Q1 FY2021 | Mar 31, 2021 | 30.1% | −16.7 |
| Q4 FY2020 | Dec 31, 2020 | 26.4% | −20.3 |
| Q3 FY2020 | Sep 30, 2020 | 26.9% | −19.8 |
| Q2 FY2020 | Jun 30, 2020 | 35.6% | +15.8 |
| Q1 FY2020 | Mar 31, 2020 | 46.7% | +21.8 |
| Q4 FY2019 | Dec 31, 2019 | 46.7% | +33.6 |
| Q3 FY2019 | Sep 30, 2019 | 46.7% | +21.8 |
| Q2 FY2019 | Jun 30, 2019 | 19.7% | −5.6 |
| Q1 FY2019 | Mar 31, 2019 | 24.9% | −6.5 |
| Q4 FY2018 | Dec 31, 2018 | 13.1% | −22.9 |
| Q3 FY2018 | Sep 30, 2018 | 24.9% | +4.8 |
| Q2 FY2018 | Jun 30, 2018 | 25.4% | −4.4 |
| Q1 FY2018 | Mar 31, 2018 | 31.4% | +20.9 |
| Q4 FY2017 | Dec 31, 2017 | 36.1% | +113.3 |
| Q3 FY2017 | Sep 30, 2017 | 20.1% | +9.6 |
| Q2 FY2017 | Jun 30, 2017 | 29.8% | – |
| Q1 FY2017 | Mar 31, 2017 | 10.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -77.2% | – |
| Q3 FY2016 | Sep 30, 2016 | 10.4% | – |
See a number that looks wrong?